Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

GENE STREET, LLC.

NPI: 1134765308 · HOUSTON, TX 77065 · Clinical Medical Laboratory · NPI assigned 11/22/2019

$1.99M
Total Medicaid Paid
10,723
Total Claims
6,376
Beneficiaries
35
Codes Billed
2020-04
First Month
2024-01
Last Month

Provider Details

Authorized OfficialALI, MIR (OWNER)
NPI Enumeration Date11/22/2019

Related Entities

Other providers sharing the same authorized official: ALI, MIR

ProviderCityStateTotal Paid
M & M PEDIATRICS, PLLC BROWNSVILLE TX $6.49M
ALI LUNG CLINIC PC SMITHFIELD NC $375K
INFECTIOUS DISEASES & EPIDEMIOLOGY PC HOPEWELL VA $237K
PULMONOLOGY & BRONCHOLOGY CLAYTON NC $169K
M & M NORTH, LLP BROWNSVILLE TX $114K
MEDINA PRIMARY CARE PLLC PLANO TX $104K
M & M PEDIATRICS, PLLC BROWNSVILLE TX $75K
DIAGNOSTIC HEART CENTER, INC ARCADIA CA $39K
SMITHFIELD PULMONOLOGY SMITHFIELD NC $30K
MIR M ALI M D A PROFESSIONAL CORPORATION ANAHEIM CA $3K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2020 881 $77K
2021 34 $1K
2022 560 $4K
2023 1,060 $14K
2024 8,188 $1.90M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
87913 9,025 4,824 $1.90M
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 73 64 $26K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 116 104 $22K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 223 208 $11K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 158 135 $10K
87481 63 59 $2K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 49 42 $2K
87541 73 64 $2K
87498 73 64 $2K
87496 73 64 $2K
87486 73 64 $2K
87581 72 63 $2K
87640 72 64 $2K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 73 66 $1K
87529 21 19 $1K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 21 19 $596.53
87653 62 59 $596.53
87641 55 52 $596.53
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 21 19 $596.53
87500 55 52 $596.53
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 20 19 $596.53
81241 18 18 $0.00
81401 18 18 $0.00
81232 18 18 $0.00
81355 18 18 $0.00
81328 18 18 $0.00
81291 18 18 $0.00
81335 18 18 $0.00
81231 18 18 $0.00
81306 18 18 $0.00
81226 18 18 $0.00
81225 18 18 $0.00
81240 18 18 $0.00
81230 18 18 $0.00
81227 18 18 $0.00